Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
AAREYDRUGS Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Low Debt to Equity, not much change from last year
Negative
Expensive and at a premium to industry median P/E
Low and declining ROE
Low but stable operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
AAREYDRUGS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
AAREYDRUGS Bulk, Block & Insider Trades
AAREYDRUGS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Rights issue
Bonus(1 new shares for 5 existing shares) Ex-date: 25th Jun 2012 Announced on: 18th May 2012
Rights issue(2 new shares @ 25 INR for 1 existing shares)Rights issue offer price is INR 25 including a premium of INR 15. Ex-date: 19th Jan 2012 Announced on: 17th Dec 2009
Company Profile
Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its... Read More
Key personnel
Mr. Mihir R. GhataliaD
Chairman of the Board, Managing Director
Mrs. Mira Mihir Ghatalia
Chief Financial Officer
Mr. Kailash Chand Jethlia
Compliance Officer, Company Secretary
Damiyanti Mike GhataliaD
Woman Director
Mr. Nimit Rajesh GhataliaD
Director
Mr. Anil MandalD
Additional Director
Chetan K. MehtaD
Non-Executive Independent Director
Shri. Lalit Radha Krishna TulsianiD
Additional Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Aarey Drugs & Pharmaceuticals Ltd.?
The current share price of Aarey Drugs & Pharmaceuticals Ltd. is ₹ 69.51 as of 09 Jan 2026.
What is the PE ratio of Aarey Drugs & Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Aarey Drugs & Pharmaceuticals Ltd. is 55.20 as of the latest financial data.
What is the ROE and ROCE of Aarey Drugs & Pharmaceuticals Ltd.?
Aarey Drugs & Pharmaceuticals Ltd. has a Return on Equity (ROE) of 2.52% and a Return on Capital Employed (ROCE) of 0.09% as per the latest financial reports.
What is the market cap of Aarey Drugs & Pharmaceuticals Ltd.?
The market capitalization of Aarey Drugs & Pharmaceuticals Ltd. stands at ₹ 197.78 Cr.
What is the dividend yield of Aarey Drugs & Pharmaceuticals Ltd.?
The dividend yield of Aarey Drugs & Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the RSI of Aarey Drugs & Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Aarey Drugs & Pharmaceuticals Ltd. is 45.18.
What is the FII and DII holding in Aarey Drugs & Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 1.13% and Domestic Institutional Investors (DII) hold 0.00% of Aarey Drugs & Pharmaceuticals Ltd. shares.
What sector does Aarey Drugs & Pharmaceuticals Ltd. belong to?
Aarey Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Aarey Drugs & Pharmaceuticals Ltd. stock?
The beta of Aarey Drugs & Pharmaceuticals Ltd. stock is 1.02, indicating its volatility relative to the broader market.
